Translational Science Benefits
Summary
Many people in therapy do not get better with evidence-based treatments, and these treatments work even less well for people who face stigma and discrimination, including LGBTQ+ patients.1-4 Clinicians say they need more support to provide good care to LGBTQ+ patients, who often deal with stress from bias, discrimination, and barriers to care.5 New state and federal policies that limit LGBTQ+ rights and access to healthcare are adding to this stress. Our earlier work shows that these policies are linked to serious emotional distress among LGBTQ+ people.6,7 Clinicians in the community need training and tools to fully address LGBTQ+ patients’ needs in this challenging policy environment.8
Measurement-based care uses brief surveys or check-ins throughout treatment to track symptoms, goals, and progress. Patients and clinicians then work together using the information to guide care decisions. Research suggests this approach can make therapy more effective and more focused on what patients care about. This may be especially helpful for LGBTQ+ patients when the measures are individualized—written in the patient’s own words, based on their specific goals, stressors, and experiences with stigma or policy-related stress. Both clinicians and patients prefer these individualized tools because they better reflect what patients are actually struggling with and hoping to change.9-11 These measures can also give LGBTQ+ patients more control over defining their goals and how progress is measured.
In this study, we will partner with community clinicians and LGBTQ+ patients to design practical strategies that help clinicians use this kind of patient-centered, measurement-based care. Our team includes experts in implementation science at Stony Brook University and experts in LGBTQ+ mental health and implementation science at Yale University, working with LGBTQ+-focused clinicians across the country.
Significance
Our main aim is to help clinicians better serve their LGBTQ+ patients.
We will work with clinicians and patients to design a strategy that supports clinicians in using measurement-based care, with an emphasis on individualized measures. The strategy will include training and ongoing resources. These measures will prompt clinicians and patients to regularly set, review, and adjust treatment goals together, giving LGBTQ+ patients more say and control in their care.
This is a pilot project. If the approach proves practical, acceptable, and easy for clinicians and patients to use, we will test it in a larger study and introduce it to more clinics across the country. This project promotes health equity by moving away from “one-size-fits-all” care. Standard treatments help fewer than half of patients and tend to be less effective for people who face stigma, discrimination, and financial hardship.1-4 By supporting clinicians to routinely check in about each patient’s specific goals and needs, we aim to make care more personalized, effective, and affirming for LGBTQ+ patients.
Benefits
Demonstrated benefits are those that have been observed and are verifiable.
Potential benefits are those logically expected with moderate to high confidence.
Clinical & medical benefits
Empower LGBTQ+ patients to have agency in their psychotherapy treatment. potential.
Primary beneficiary:
Patients
Inform how to better design measurement-based care to make it contextually sensitive and patient-centered. potential.
Primary beneficiary:
Clinicians
Community & public health benefits
Engage LGBTQ+ patients and their clinicians to improve the effectiveness and patient-centeredness of treatment. potential.
Primary beneficiary:
Patients
Improve the effectiveness of treatment for LGBTQ+ patients. potential.
Primary beneficiary:
Patients
This research has clinical and community implications. The framework for these implications was derived from the Translational Science Benefits Model created by the Institute of Clinical & Translational Sciences at Washington University in St. Louis.12
Clinical
This pilot project will test whether using individualized measures within measurement-based care is more effective and patient-centered for LGBTQ+ patients in real-world settings. The findings will inform a future, larger randomized clinical trial in community clinics. Our early work focuses on making sure that the approach is feasible, acceptable, easy to use, and aligned with the needs of both clinicians and LGBTQ+ patients.
Community
Our work will help identify effective, evidence-based ways for clinicians to create more individualized care plans with LGBTQ+ patients who face unique stigma-related stressors. There is a clear need for care that is both effective and tailored to each patient’s specific treatment needs. Current treatment models often use a one-size-fits-all approach. Measurement-based care can advance health equity by ensuring LGBTQ+ patients’ concerns, goals, and stressors are actively included in treatment.
Lessons Learned
If the project is successful, it will show that clinicians and LGBTQ+ patients are willing to use measurement-based care when it feels relevant and supportive. We expect that both groups will find it valuable when clinicians receive enough support and when the measures are flexible and personalized. We also expect that LGBTQ+ patients will appreciate having more power to shape their own treatment around their needs, goals, and life circumstances.
- Cuijpers P, Karyotaki E, Ciharova M, Miguel C, Noma H, Furukawa TA. The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: A meta-analysis. Acta Psychiatr Scand. 2021;144(3):288-299. doi:10.1111/acps.13335
- Cuijpers P, Karyotaki E, Ciharova M, et al. The effects of psychological treatments of depression in children and adolescents on response, reliable change, and deterioration: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2023;32(1):177-192. doi:10.1007/s00787-021-01884-6
- Price MA, Weisz JR, McKettaS, et al. Meta-analysis: Are psychotherapies less effective for Black youth in communities with higher levels of anti-Black racism? J Am Acad Child Adolesc Psychiatry. 2022;61(6):754-763. doi: 10.1016/j.jaac.2021.07.808
- Finegan M, Firth N, Wojnarowski C, Delgadillo J. Associations between socioeconomic status and psychological therapy outcomes: A systematic review and meta‐analysis. Depress Anxiety. 2018;35(6):560-573. doi:10.1002/da.22765
- Pachankis JE, Clark KA, Jackson SD, Pereira K, Levine D. Current capacity and future implementation of mental health services in US LGBTQ community centers. PsychiatrServ. 2021;72(6):669-676. doi:10.1176/appi.ps.202000575
- Last BS, Tran NK, Lubensky ME, Obedin-Maliver J, Lunn MR, Flentje A. US State Policies and Mental Health Symptoms Among Sexual and Gender Minority Adults. JAMA Netw Open. 2025;8(5):e2512189-e2512189. doi: 10.1001/jamanetworkopen.2025.12189
- Last BS, Poupard M, Williamson N, et al. LGBTQIA+ people’s perspectives on LGBTQIA+-targeted state policies and mental health: a qualitative study. JAMANetw Open. 2026;9(1):e2546538-e2546538. doi:10.1001/jamanetworkopen.2025.46538
- Rees SN, Crowe M, Harris S. The lesbian, gay, bisexual and transgender communities’ mental health care needs and experiences of mental health services: An integrative review of qualitative studies. J Psychiatr Ment Health Nurs. 2021;28(4):578-589. doi:10.1111/jpm.12720
- Jensen-Doss A, Smith AM, Becker-Haimes EM, et al. Individualized progress measures are more acceptable to clinicians than standardized measures: Results of a national survey. Adm Policy Ment Health Ment Health Serv Res.2018;45:392-403. doi:10.1007/s10488-017-0833-y
- Lloyd CEM, Duncan C, Cooper M. Goal measures for psychotherapy: A systematic review of self‐report, idiographic instruments. Clin Psychol SciPract. 2019;26(3). doi:10.1111/cpsp.12281
- Solstad SM, Cooper M, Sundet R, Moltu C. Effects and experiences of idiographic patient-reported outcome measures for feedback in psychotherapy: A systematic review and secondary analysis of the empirical literature. Psychother Res. 2025;35(1):125-138. doi:10.1080/10503307.2023.2283528
- Luke DA, Sarli CC, Suiter AM, et al. The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences. Clin Transl Sci. 2018;11(1):77-84. doi:10.1111/cts.12495